Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Jardiance (empagliflozin) and glipizide are both medications used to treat Type 2 diabetes, but they work in different ways and belong to different drug classes. Jardiance is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar by causing your body to get rid of excess sugar through urine. It also has benefits for heart failure and chronic kidney disease. Glipizide, on the other hand, is a sulfonylurea that lowers blood sugar by telling your pancreas to release more insulin. Jardiance is taken once daily and is only available as a brand-name medication, with generics expected in 2025. Glipizide can be taken once or twice daily and is available as a lower-cost generic. While Jardiance can cause urinary tract and yeast infections, Glipizide can lead to dangerously low blood sugar levels, especially if you skip meals. Additionally, glipizide may cause weight gain, whereas Jardiance is not likely to cause weight gain and may even lead to some weight loss.
Glipizide is a sulfonylurea medication used to treat Type 2 diabetes in adults. It lowers blood sugar levels by telling your pancreas to release more insulin. Glipizide is taken by mouth, typically once or twice daily. Some side effects of this medication include dizziness and diarrhea. Taking glipizide can also put you at risk for dangerously low blood sugar, so it's important to take this medication with meals.
Indications of Jardiance vs. Glucotrol
Indications for
•Type 2 diabetes (in addition to diet and exercise) in people age 10 years and older
•Lowering the risk of death due to heart problems in adults with Type 2 diabetes and heart disease
•Lowering the risk of hospitalization and death due to heart problems in adults with heart failure
•Lowering the risk of worsening kidney problems, hospitalization, and death due to heart problems in adults with chronic kidney disease (CKD)